Stockreport

Liquidia Continues To Expand Their Growth Vs. MannKind's Growth In Share Prices [Seeking Alpha]

Liquidia Corporation  (LQDA) 
Last liquidia corporation earnings: 3/11 07:00 am Check Earnings Report
PDF Liquidia's PAH drug, Yutrepia, is expected to launch in the first or second quarter of 2024, potentially leading to profitability. Liquidia has gained a major partner [Read more]